Salvestrols: Nature's Defence Against Cancer

Salvestrols are "The most significant breakthrough in nutrition since the discovery of vitamins." Salvestrols are a new class of natural compounds that have a pharmacological definition rather than a chemical definition. They are defined by the action of the metabolites produced when they are metabolised by the CYP1B1 enzyme in cancer cells. Simply put, salvestrols are food-based compounds that are metabolised by CYP1B1 to produce metabolites that are anticancer agents. These anticancer agents suppress tumour growth by killing the cancer cells. Salvestrols provide an explanation of the link between diet and cancer and between fruit and vegetable consumption and lower cancer incidence. There has to be a significant change in the way that we approach food, in the way we grow food and the way that we see our diet. Anthony Daniels I never believed that cancer was a curable disease. Now, in the light of what we have discovered, I believe that cancer is curable. Professor Gerry Potter

Author: Brian a. Schaefer
Publisher: Independently Published
Published: 09/19/2018
Pages: 212
Binding Type: Paperback
Weight: 0.54lbs
Size: 7.99h x 5.24w x 0.48d
ISBN13: 9781723850394
ISBN10: 172385039X
BISAC Categories:
- Medical | Diet Therapy
- Health & Fitness | Diseases | Cancer
- Health & Fitness | Diet & Nutrition | General

About the Author
The author was educated in Victoria, B.C., Canada and Oxford, England, obtained a B.Sc., and M.Sc., degree from the University of Victoria and a Doctor of Philosophy (D.Phil.) degree from Oxford University in England (Wolfson College). After these studies were completed he chose to return to Canada. After two years as a research fellow in Ottawa he returned to Victoria where he currently lives with his wife and his two children. A fondness for England continues and he returns to England on a regular basis. He has published and lectured on a broad array of topics including psychometrics, pattern recognition, visual perception, knowledge acquisition, artificial intelligence, laboratory medicine and cancer research. The author serves on the Board of Directors of companies in Canada and England.

This title is not returnable